Demonstrates a covalent platform enabling long-term protein tracking in living cells, indicating potential for biomedical applications.
Long-term imaging of the protein dynamics within living cells is crucial for understanding the mechanism of disease occurrence and developing efficient diagnosis and treatment. However, the current probes suffer from a short intracellular retention and rapid clearance. Herein, we develop a covalent targeted imaging platform (CTI) for protein dynamic tracking in living cells. The peptide-conjugated probe can achieve covalent recognition of the target protein with a peptide ligand. In tandem, the maleimide group reacts with a cysteine sulfhydryl group on the target protein to form a covalent bond. This bond formation concomitantly restricts the rotation of a fluorescent molecular rotor, resulting in the activation of a long-term fluorescent signal. As a proof of concept, the probe (MXQ) successfully enabled long-term stable tracking and precise treatment monitoring of the X-linked inhibitor of apoptosis protein (XIAP) within living MCF-7 cells. We have, for the first time, reported a covalent targeted and generalizable platform for potentially accelerating its biomedical application for diverse diseases.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: